Blood Flow Restriction Therapy

like what you see? share...Share on Facebook
Facebook
Share on Google+
Google+
Tweet about this on Twitter
Twitter
Share on LinkedIn
Linkedin

blood flow restriction therapy Frisco

Blood Flow Restriction Therapy is a new tool used to decrease the time to return to sport postoperatively.
(http://www.sportsmed.org/AOSSMIMIS/members/downloads/SMU/2017Spring.pdf)

After an injury or surgery, the body’s ability to increase strength is significantly compromised. Individuals who are not able to bear weight or have chronic pain can suffer from muscle atrophy which can take 6-12 months to recover from. Now a patient no longer has to run the risk of significant muscle atrophy during the early recovery phases when Blood Flow Restriction Therapy (BFRT) is combined with low intensity resistance training. (https://www.ncbi.nlm.nih.gov/pubmed/20175789)

Blood Flow Restriction (BFR) Has Been Scientifically Proven To:

  • Significantly increase muscle size (hypertrophy) and strength with less resistance, quicker than traditional therapy. (https://www.ncbi.nlm.nih.gov/pubmed/24476782)
  • Patients have less soreness and muscle fatigue 24 hours after treatment than traditional strength methods.

BFR also provides a natural increase in factors that improve healing such as:

  • Human Growth Hormone
  • Insulin Like Growth Factor
  • Myogenic Stem Cells
  • Decrease in Myostatin Improving Strength

Blood flow restriction therapy is a relatively new technique used by physical therapists to help promote healing in athletes with less risk of re-injury. It is currently being used by 57 major university sports programs, 20 NBA teams, 23 NFL teams, 19 MLB teams and 10 NHL teams nationwide.

Written by the Therapy Team at Frisco Physical Therapy – Frisco, Texas. Frisco Physical Therapy is currently providing blood flow restriction therapy for its patients. The licensed therapists have completed additional training courses in order to provide this service.
To learn more about Frisco Physical Therapy click here.